We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+5.38%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$37.4B
AUM Growth
–
Cap. Flow
+$36.9B
Cap. Flow
% of AUM
98.59%
Top 10 Holdings %
Top 10 Hldgs %
18.88%
Holding
891
New
889
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$1.06B |
| 2 |
ExxonMobil
XOM
|
+$892M |
| 3 |
Pfizer
PFE
|
+$836M |
| 4 |
JPMorgan Chase
JPM
|
+$811M |
| 5 |
Wells Fargo
WFC
|
+$694M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.97% |
| 2 | Technology | 13.77% |
| 3 | Healthcare | 13.62% |
| 4 | Energy | 13.22% |
| 5 | Industrials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Assurant
AIZ
$13.3B
| $169M | 0.45% |
+3,317,386
| New | +$161M |
2013 Q2
0 quarters
|
|
77
Entergy
ETR
$49.5B
| $168M | 0.45% |
+4,826,580
| New | +$166M |
2013 Q2
0 quarters
|
|
78
MetLife
MET
$63.4B
| $168M | 0.45% |
+4,112,740
| New | +$151M |
2013 Q2
0 quarters
|
|
79
DELISTED
PARTNERRE LTD
PRE
| $166M | 0.44% |
+1,833,214
| New | +$167M |
2013 Q2
0 quarters
|
|
80
APA Corp
APA
$16.5B
| $166M | 0.44% |
+1,978,131
| New | +$157M |
2013 Q2
0 quarters
|
|
81
Medtronic
MDT
$117B
| $164M | 0.44% |
+3,195,058
| New | +$158M |
2013 Q2
0 quarters
|
|
82
GameStop
GME
$13.4B
| $162M | 0.43% |
+15,400,876
| New | +$136M |
2013 Q2
0 quarters
|
|
83
Lear
LEA
$5.82B
| $156M | 0.42% |
+2,585,460
| New | +$149M |
2013 Q2
0 quarters
|
|
84
Eastman Chemical
EMN
$7.19B
| $156M | 0.42% |
+2,232,448
| New | +$156M |
2013 Q2
0 quarters
|
|
85
KeyCorp
KEY
$21.5B
| $156M | 0.42% |
+14,145,630
| New | +$145M |
2013 Q2
0 quarters
|
|
|
STJ
86
DELISTED
St Jude Medical
STJ
| $155M | 0.41% |
+3,405,200
| New | +$148M |
2013 Q2
0 quarters
|
|
87
Helmerich & Payne
HP
$3.91B
| $153M | 0.41% |
+2,445,700
| New | +$151M |
2013 Q2
0 quarters
|
|
88
Cigna
CI
$74.7B
| $147M | 0.39% |
+2,032,041
| New | +$137M |
2013 Q2
0 quarters
|
|
89
Aflac
AFL
$58.3B
| $147M | 0.39% |
+5,043,800
| New | +$137M |
2013 Q2
0 quarters
|
|
90
Baxter International
BAX
$12.8B
| $143M | 0.38% |
+3,797,817
| New | +$145M |
2013 Q2
0 quarters
|
|
91
Timken Company
TKR
$8.06B
| $143M | 0.38% |
+3,537,369
| New | +$140M |
2013 Q2
0 quarters
|
|
|
VR
92
DELISTED
Validus Hold Ltd
VR
| $132M | 0.35% |
+3,651,335
| New | +$135M |
2013 Q2
0 quarters
|
|
|
ENDP
93
DELISTED
Endo International plc
ENDP
| $131M | 0.35% |
+3,568,302
| New | +$128M |
2013 Q2
0 quarters
|
|
94
Abbott
ABT
$175B
| $130M | 0.35% |
+3,720,525
| New | +$136M |
2013 Q2
0 quarters
|
|
95
Unum
UNM
$14.7B
| $129M | 0.34% |
+4,379,250
| New | +$122M |
2013 Q2
0 quarters
|
|
96
CF Industries
CF
$17.3B
| $125M | 0.33% |
+3,644,800
| New | +$136M |
2013 Q2
0 quarters
|
|
97
Johnson & Johnson
JNJ
$635B
| $117M | 0.31% |
+1,368,400
| New | +$116M |
2013 Q2
0 quarters
|
|
|
DNY
98
DELISTED
DONNELLEY R R & SONS CO
DNY
| $114M | 0.31% |
+8,169,863
| New | +$114M |
2013 Q2
0 quarters
|
|
99
Regions Financial
RF
$23.4B
| $114M | 0.3% |
+11,957,732
| New | +$104M |
2013 Q2
0 quarters
|
|
|
LXK
100
DELISTED
Lexmark Intl Inc
LXK
| $112M | 0.3% |
+3,672,468
| New | +$108M |
2013 Q2
0 quarters
|
|
Similar funds
HF
LSV Asset Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for LSV Asset Management, which disclosed 891 positions worth $37.4B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is Chevron: 8,761,938 shares worth $1.04B.
By sector, the portfolio is most concentrated in Financials at 25% of assets, followed by Technology and Healthcare.
- LSV Asset Management's largest Q2 2013 buy was Chevron: 8,761,938 shares worth $1.04B.
- LSV Asset Management's ten largest holdings make up 19% of its $37.4B portfolio in Q2 2013.
- LSV Asset Management disclosed 891 positions in Q2 2013, its first 13F filing on record.
Based on LSV Asset Management's 13F filing for Q2 2013, filed 12 Aug 2013.